Výsledky vyhledávání - "Sreeni Chittoor"

Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy

Publikováno v: Journal of Clinical Oncology. 25:4765-4771

Purpose Hormonal breast cancer treatment increases menopausal symptoms in women. This study investigated differences between the symptoms associated with either adjuvant tamoxifen or exemestane. Patients and Methods Ten common symptoms were assessed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01584907be43b026d8d3a817ea271ddc
https://doi.org/10.1200/jco.2007.10.8274

Zobrazit plný text záznamu

Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer

Autor: Feng Zhan, William R. Berry, Sreeni Chittoor, John Fleagle, Stephanie Mull, Lina Asmar, Kristi A. Boehm, David M. Loesch, Keith W. Logie

Publikováno v: Clinical Genitourinary Cancer. 5:212-218

Chemotherapy is often poorly tolerated in elderly patients or patients with poor performance status. This trial was designed to determine whether low-dose weekly docetaxel/estramustine was efficacious with acceptable toxicity.Dexamethasone was admini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c9f21a2459273506a999c7637157d8
https://doi.org/10.3816/cgc.2006.n.039

Zobrazit plný text záznamu

Sticky Platelet Syndrome: A Case Report and Review of the Literature

Autor: Gary F. Roberts, Sreeni Chittoor, Ahmed E. Elsehety, W. Robert Laughlin

Publikováno v: Clinical and Applied Thrombosis/Hemostasis. 4:280-284

Thrombosis has been attributed to platelet function abnormalities in a variety of vascular diseases. A patient with superior sagittal sinus thrombosis noted to have a normal work- up for hypercoagulable state but who had hyperaggregability of platele

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8e1c215ed90eac78cde9f1bf3670275
https://doi.org/10.1177/107602969800400413

Zobrazit plný text záznamu

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial

Autor: Marcus A. Neubauer, Allen Lee Cohn, John Robert Caton, Lawrence Garbo, Scott Brian Saxman, Francisco Robert, Edward S. Kim, Craig W. Reynolds, Lorinda Simms, Terry L. Katz, Sreeni Chittoor, Lee S. Schwartzberg

Publikováno v: The Lancet. Oncology. 14(13)

Summary Background Available preclinical and phase 2 clinical data suggest that the addition of cetuximab, a monoclonal antibody directed against the epidermal growth factor receptor (EGFR), to chemotherapy might improve outcome in patients with adva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd7ebe3f8f2c6ce4f2ffc2a40f6a359
https://pubmed.ncbi.nlm.nih.gov/24281063

Zobrazit plný text záznamu

Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age ≥75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3

Autor: J. Fleagle, S. Mull, David M. Loesch, Sreeni Chittoor, K. W. Logie, Lina Asmar, Feng Zhan, Kristi A. Boehm, William R. Berry

Publikováno v: Journal of Clinical Oncology. 23:4646-4646

4646 Background: Chemotherapy is often poorly tolerated in the elderly or subjects with poor PS. This trial was designed to determine if docetaxel and estramustine, delivered weekly in less than st...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4017b4d11450f5a01e58c03f3e6a1cb
https://doi.org/10.1200/jco.2005.23.16_suppl.4646

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání